Protara Therapeutics, Inc. (TARA) NASDAQ

3.14

-0.0436(-1.37%)

Updated at July 31 11:04AM

Currency In USD

Valuation

Market Cap108.73M
Enterprise Value-49.58M
P/E Ratio-2.85
PEG Ratio-0.11
Price/Sales Ratio0
Price/Book Ratio0.82
Enterprise/Revenue0
Enterprise/EBITDA-0.69

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.27
Return On Equity-0.36

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-49.15M
Net Income-44.6M
Diluted EPS-2.17

Balance Sheet

Total Cash124.36M
Total Cash/Share3.06
Total Debt4.23M
Total Debt/Equity0.03
Current Ratio18.03
Book Value Per Share3.89

Price History

52-Week Change42.6
52-Week High10.48
52-Week Low1.6
Moving Average 50 Days3.15
Moving Average 200 Days3.71

Statistics

Average Volume339,104
Shares Outstanding38.58M
% Held by Institutions68.68

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor1:40
Last Split DateJanuary 10, 2020